Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CCR4-NOT transcription complex subunit 3 (CNOT3)
- Target
- CNOT3
- Molecular classification
- Transcription factor, Deadenylase subunit, RNA-binding protein
01
Overview
CCR4-NOT transcription complex subunit 3 (CNOT3) is a core component of the CCR4-NOT complex, a highly conserved multiprotein complex in eukaryotes. It plays a central role in regulating gene expression at multiple levels, including transcriptional regulation, mRNA deadenylation and decay, translational repression, and maintenance of stem cell populations. CNOT3 functions include repression of transcription, regulation of mRNA degradation and miRNA-mediated repression, translational repression during initiation phases, and general regulation of gene expression at both nuclear and cytoplasmic levels. It may also be involved in metabolic regulation and mitotic progression.
- Other names
- NOT3
02
Mechanism of action
Not applicable, CNOT3 is a protein target, not a drug.
03
Biological functions
Repression of transcriptionRegulation of mRNA deadenylation and decayTranslational repressionStem cell maintenanceMitotic progressionMetabolic regulationRegulation of gene expression
04
Disease associations
Intellectual Developmental Disorder With Speech Delay, Autism, And Dysmorphic FaciesPrecursor T-cell Acute Lymphoblastic Leukemia
05
Safety considerations
Dysregulation can lead to developmental disorders and cancer.Inhibition may affect stem cell maintenance and normal cell cycle progression.
Beyond the preview
Go deeper on CCR4-NOT transcription complex subunit 3 (CNOT3).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CCR4-NOT transcription complex subunit 3 (CNOT3).